Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:681-686, doi:10.1016/S0735-1097(02)02893-0
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanno, S.
Right arrow Articles by Saffitz, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanno, S.
Right arrow Articles by Saffitz, J. E.

CLINICAL STUDY: CONNEXIN AND INFARCTION

Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice

Shigeto Kanno, MD, PhD*, Attila Kovacs, MD*, Kathryn A. Yamada, PhD* and Jeffrey E. Saffitz, MD, PhD, FACC*,*

* Departments of Surgery, Medicine, and Pathology, and the Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, Missouri, USA

Manuscript received July 12, 2002; revised manuscript received September 30, 2002, accepted November 19, 2002.

* Reprint requests and correspondence: Dr. Jeffrey E. Saffitz, Washington University, Department of Pathology, Box 8118, 660 South Euclid Avenue, St. Louis, Missouri 63110USA.

OBJECTIVES: The purpose of this study was to define the role of cell–cell coupling as an independent determinant of infarct size following coronary occlusion.

BACKGROUND: Electrical uncoupling induced by acute ischemia enhances arrhythmogenesis, but it may also protect the heart by limiting intercellular spread of chemical mediators of injury.

METHODS: The left anterior descending coronary artery was ligated in wild-type (Cx43+/+) mice and Cx43-deficient (Cx43+/–) mice that are heterozygous for a null allele in the gene encoding the major gap junction channel protein, connexin43 (Cx43). Ventricular remodeling and infarct size were compared in both groups.

RESULTS: Echocardiography at 1 and 10 weeks after infarction showed that left ventricular end-diastolic volume and mass increased and ejection fraction decreased in proportion to infarct size in both Cx43+/– and Cx43+/+ hearts. However, infarct size measured histologically in healing infarcts (eight days after infarction) was 29% smaller in Cx43+/– hearts (17 ± 14% of total left ventricular area, n = 30) than in Cx43+/+ hearts (24 ± 15%, n = 23; p = 0.037). Fully healed infarcts were smaller than healing infarcts, owing to resorption of necrotic tissue and maturation of scar, but infarct size at 10 weeks after coronary occlusion was still smaller (by 50%) in Cx43+/– hearts (6 ± 5%, n = 9) compared with Cx43+/+ hearts (12 ± 7%, n = 17; p = 0.037).

CONCLUSIONS: Cx43-deficient mice develop smaller infarcts than wild-type mice following coronary ligation. New therapies designed to decrease the risk of arrhythmias by enhancing intercellular communication could lead to larger infarcts caused by persistent coronary occlusion.

Abbreviations and Acronyms
  Cx43
  connexin43
  Cx43+/+
  mice with two wild-type alleles for the Cx43 gene
  Cx43+/–
  mice with one null allele for the Cx43 gene
  LAD
  left anterior descending coronary artery
  LV
  left ventricle or ventricular
  MI
  myocardial infarct or infarction




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. Maass, S. E. Chase, X. Lin, and M. Delmar
Cx43 CT domain influences infarct size and susceptibility to ventricular tachyarrhythmias in acute myocardial infarction
Cardiovasc Res, December 1, 2009; 84(3): 361 - 367.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Wang and Y. Cheng
The tail of Cx43: its crucial protective role in acute myocardial infarction
Cardiovasc Res, December 1, 2009; 84(3): 337 - 338.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Rodriguez-Sinovas
Cx43 phosphorylation and cardioprotection
Cardiovasc Res, September 1, 2009; 83(4): 613 - 614.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Hagen, A. Dietze, and S. Dhein
Human cardiac gap-junction coupling: effects of antiarrhythmic peptide AAP10
Cardiovasc Res, July 15, 2009; 83(2): 405 - 415.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. J. Severs, A. F. Bruce, E. Dupont, and S. Rothery
Remodelling of gap junctions and connexin expression in diseased myocardium
Cardiovasc Res, October 1, 2008; 80(1): 9 - 19.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. H.-C. Lin, N. Lou, N. Kang, T. Takano, F. Hu, X. Han, Q. Xu, D. Lovatt, A. Torres, K. Willecke, et al.
A Central Role of Connexin 43 in Hypoxic Preconditioning
J. Neurosci., January 16, 2008; 28(3): 681 - 695.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Ruiz-Meana, A. Rodriguez-Sinovas, A. Cabestrero, K. Boengler, G. Heusch, and D. Garcia-Dorado
Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury
Cardiovasc Res, January 15, 2008; 77(2): 325 - 333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Wit and H. S. Duffy
Drug development for treatment of cardiac arrhythmias: targeting the gap junctions
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H16 - H18.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Murphy and C. Steenbergen
Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury
Cardiovasc Res, August 1, 2007; 75(3): 478 - 486.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Kojodjojo, P. Kanagaratnam, O. R. Segal, W. Hussain, and N. S. Peters
The Effects of Carbenoxolone on Human Myocardial Conduction: A Tool to Investigate the Role of Gap Junctional Uncoupling in Human Arrhythmogenesis
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1242 - 1249.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. K. Hennan, R. E. Swillo, G. A. Morgan, J. C. Keith Jr., R. G. Schaub, R. P. Smith, H. S. Feldman, K. Haugan, J. Kantrowitz, P. J. Wang, et al.
Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 236 - 243.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler
Protective effect of gap junction uncouplers given during hypoxia against reoxygenation injury in isolated rat hearts
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H648 - H656.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. A. Iacobas, S. Iacobas, W. E. I. Li, G. Zoidl, R. Dermietzel, and D. C. Spray
Genes controlling multiple functional pathways are transcriptionally regulated in connexin43 null mouse heart
Physiol Genomics, February 10, 2005; 20(3): 211 - 223.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. S. Turner, G. A. Haywood, P. Andreka, L. You, P. E. Martin, W. H. Evans, K. A. Webster, and N. H. Bishopric
Reversible Connexin 43 Dephosphorylation During Hypoxia and Reoxygenation Is Linked to Cellular ATP Levels
Circ. Res., October 1, 2004; 95(7): 726 - 733.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler
Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium
J. Physiol., August 15, 2004; 559(1): 245 - 257.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T.-M. Lee, M.-S. Lin, T.-F. Chou, C.-H. Tsai, and N.-C. Chang
Adjunctive 17{beta}-estradiol administration reduces infarct size by altered expression of canine myocardial connexin43 protein
Cardiovasc Res, July 1, 2004; 63(1): 109 - 117.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Dhein
Pharmacology of gap junctions in the cardiovascular system
Cardiovasc Res, May 1, 2004; 62(2): 287 - 298.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Gros, L. Dupays, S. Alcolea, S. Meysen, L. Miquerol, and M. Theveniau-Ruissy
Genetically modified mice: tools to decode the functions of connexins in the heart--new models for cardiovascular research
Cardiovasc Res, May 1, 2004; 62(2): 299 - 308.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Schulz and G. Heusch
Connexin 43 and ischemic preconditioning
Cardiovasc Res, May 1, 2004; 62(2): 335 - 344.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. J. Severs, S. R. Coppen, E. Dupont, H.-I Yeh, Y.-S. Ko, and T. Matsushita
Gap junction alterations in human cardiac disease
Cardiovasc Res, May 1, 2004; 62(2): 368 - 377.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Camelliti, G. P Devlin, K. G Matthews, P. Kohl, and C. R Green
Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction
Cardiovasc Res, May 1, 2004; 62(2): 415 - 425.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Gattenlohner, C. Waller, G. Ertl, B.-D. Bultmann, H.-K. Muller-Hermelink, and A. Marx
NCAM(CD56) and RUNX1(AML1) Are Up-Regulated in Human Ischemic Cardiomyopathy and a Rat Model of Chronic Cardiac Ischemia
Am. J. Pathol., September 1, 2003; 163(3): 1081 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Gu, F. C. Smith, S. M. Taffet, and M. Delmar
High Incidence of Cardiac Malformations in Connexin40-Deficient Mice
Circ. Res., August 8, 2003; 93(3): 201 - 206.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement